← BRASKEM SA

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Net sales and services revenue $47.7b
$49.3b +3.35%
$58.0b +17.74%
$52.3b -9.79%
$58.5b +11.89%
$105.6b +80.42%
$96.5b -8.62%
$70.6b -26.89%
$77.4b +9.70%
$70.7b -8.65%
—
Revenue From Interest $646.7m $512.1m — — — — — — — — —
Cost of Goods and Services Sold $35.0b
$36.2b +3.41%
$46.4b +28.34%
$45.9b -1.19%
$47.3b +3.17%
$73.6b +55.43%
$85.2b +15.76%
$67.5b -20.68%
$71.4b +5.72%
$57.1b -20.09%
$65.4b +14.60%
Cost of products sold ($35.0b)
($36.2b) -3.41%
($46.4b) -28.34%
($45.9b) +1.19%
($47.3b) -3.17%
($73.6b) -55.43%
($85.2b) -15.76%
($67.5b) +20.68%
($71.4b) -5.72%
($69.2b) +3.15%
—
Gross Profit $12.7b
$13.1b +3.19%
$11.6b -11.58%
$6.4b -44.29%
$11.2b +73.98%
$32.1b +185.91%
$11.4b -64.57%
$3.0b -73.40%
$6.0b +98.51%
$1.6b -74.05%
$1.3b -13.50%
Research And Development Expense $162.0m $167.5m $199.8m $247.7m $250.6m $296.6m $374.5m $383.0m $463.0m $460.0m $436.0m
Selling, General and Administrative Expense ($2.9b) ($3.1b) ($3.4b) $4.3b $4.1b ($4.9b) ($5.3b) — — — $4.7b
EBIT $3.4b ($1.9b) ($12.3b) $2.4b $2.6b
Operating Income $6.0b
$9.2b +54.71%
$8.3b -10.07%
$153.7m -98.14%
($71.9m) -146.78%
$26.0b +36325.93%
$6.1b -76.53%
($1.8b) -128.63%
($990.0m) +43.43%
($1.6b) -65.86%
($752.0m) +54.20%
Other Operating Income Expense ($3.9b) ($854.9m) $90.9m ($2.0b) ($7.2b) ($1.1b) ($1.8b) ($966.0m) ($2.1b) — —
Interest Expense $2.4b $2.2b — ($2.5b) ($6.7b) $14.0b $3.3b $4.2b $5.4b $5.2b $5.3b
Interest Expense On Lease Liabilities — — — ($128.4m) $189.2m ($198.2m) $221.0m $279.0m $261.0m — $5.3b
Interest Income $690.1m $603.6m $589.1m $850.6m $600.2m $1.8b $2.0b $1.7b $1.7b $2.3b $652.0m
Income from Equity Method Investments $30.1m $40.0m ($888k) $10.2m ($19.4m) $4.6m $34.8m $7.0m ($21.0m) $9.0m —
Non-Operating Income (Expense) — $314.9m $1.0b $2.4b $750.7m $1.5b $507.3m $1.8b $978.0m $3.2b —
Other Income — $314.9m $1.0b $2.4b $750.7m $1.5b $507.3m $1.8b $978.0m $3.2b —
Other expenses — ($1.2b) ($554.7m) ($4.4b) ($7.9b) ($2.7b) ($2.3b) ($2.7b) ($3.0b) ($1.3b) —
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method $30.1m $40.0m ($888k) $10.2m ($19.4m) $4.6m $34.8m $7.0m ($21.0m) $9.0m —
(Loss) before income tax ($140.0m) $5.3b $3.6b ($4.6b) ($9.7b) $18.0b $47.3m ($6.2b) ($17.7b) ($2.8b) —
Current Tax Expense (Income) ($411.5m) $3.9b $509.8m ($228.9m) ($52.8m) ($3.8b) ($1.0b) ($191.0m) — — —
Deferred Tax Expense (Income) ($411.5m) — $226.8m $2.2b $2.7b ($165.0m) $136.0m $1.5b $6.5b — —
Deferred Tax Expense (Income) Recognised In Profit Or Loss $140.0m $5.3b ($235.5m) $4.6b $9.7b $18.0b $47.3m $6.2b $17.7b $2.8b —
Income Tax Expense Continuing Operations $616.0m $1.4b $736.6m ($2.0b) ($2.7b) $4.0b $867.7m ($1.3b) ($5.7b) — $7.6b
Income taxes ($616.0m) ($1.4b) ($736.6m) $2.0b $2.7b ($4.0b) ($867.7m) $1.3b $5.7b ($8.1b) —
Net Income ($411.5m)
$3.9b +1039.42%
$2.8b -26.85%
($2.5b) -189.86%
($6.7b) -163.35%
$14.0b +308.99%
($336.0m) -102.40%
($4.6b) -1262.80%
($11.3b) -147.22%
($9.9b)
($9.1b) +7.57%
Basic Earnings (Loss) Per Share ($0.52) $4.86 $3.55 ($3.19) ($8.41) $17.57 ($1.26) ($17.24) ($42.60) ($37.18) ($22.91)
Diluted Earnings (Loss) Per Share ($0.52) $4.86 $3.55 ($3.19) ($8.41) $17.57 ($1.26) ($17.24) ($42.60) ($37.18) ($22.91)
Additional Financial Items
(Loss) before financial results and taxes $6.0b $9.2b $8.3b $153.7m ($71.9m) $26.0b $4.3b ($2.8b) ($1.1b) ($1.8b) —
Administrative Expense $1.3b $1.4b — — — — — — — — —
Applicable Tax Rate — $0 — — — — — — — — —
Average Effective Tax Rate $0 $3.9b $2.8b $0 $0 $0 $18 $0 $0 — —
Depreciation And Amortisation Expense ($2.7b) ($2.9b) — — — — — — — — —
Depreciation Right of Use Assets — — $2.8b $500.8m $740.2m ($877.0m) ($995.3m) $1.3b $1.1b — —
Derivatives and exchange rate variations, net ($3.2b) ($798.8m) ($2.3b) ($1.7b) ($5.3b) ($4.0b) ($572.2m) $511.0m ($11.5b) $3.5b —
Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used — — — $1.1m $981k $7.2b $42.0m — — — —
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used — — — $103.9m — — — — — — —
Finance Costs $3.6b $3.7b $3.0b $3.9b $4.9b $5.9b $5.7b $5.6b $6.9b — —
Finance Income $690.1m $603.6m $589.1m $850.6m $600.2m $1.8b $2.0b $1.7b $1.7b $2.3b —
Financial expenses ($3.6b) ($3.7b) ($3.0b) ($3.9b) ($4.9b) ($5.9b) ($5.7b) ($5.6b) ($6.9b) ($6.8b) —
Loss for the year ($729.2m) $3.9b $2.9b ($2.6b) ($7.0b) $14.0b ($820.4m) ($4.9b) ($12.1b) ($11.0b) —
Non-controlling interest in subsidiaries ($317.7m) $50.3m $40.5m ($99.4m) ($323.6m) ($23.3m) ($484.7m) ($311.0m) ($732.0m) ($1.1b) —
Other Finance Cost $201.5m $849.5m — — — — — — — — —
Profit Loss Attributable To Noncontrolling Interests ($317.7m) $50.3m $40.5m ($99.4m) ($323.6m) ($23.3m) ($484.7m) ($311.0m) ($732.0m) ($1.1b) —
Profit Loss Attributable To Owners Of Parent ($411.5m) $3.9b $2.8b ($2.5b) ($6.7b) $14.0b ($335.7m) ($4.6b) ($11.3b) ($9.9b) —
Profit Loss Before Tax ($140.0m) $5.3b $3.6b ($4.6b) ($9.7b) $18.0b $47.3m ($6.2b) ($17.7b) ($2.8b) —
Profit Loss From Operating Activities $6.0b $9.2b $8.3b $153.7m ($71.9m) $26.0b $4.3b ($2.8b) ($1.1b) ($1.8b) —
Reversal of (loss for) impairment of trade accounts receivable and others from clients — — — — — — ($38.0m) ($83.0m) $108.0m ($125.0m) —
Selling Expense $7.2m — — — — — — — — — —
Selling and distribution ($1.4b) ($1.5b) ($1.5b) ($1.8b) ($1.9b) ($2.1b) ($2.1b) ($1.9b) ($2.0b) ($2.1b) —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.